| THURSDAY,
APRIL 24, 2003 |
| 16:00 |
Arrival &Registration |
| 18:30 |
Get-Together Reception |
| FRIDAY,
APRIL 25, 2003 08:30–18:00 |
 |
HALL A |
HALL B |
HALL C |
|
|
Infertility & ART |
Gynecology/ Menopause & Family Planning |
Perinatology & Prenatal Diagnosis |
| 08:30 |
Cloning &Stem Cells |
Family Planning |
Mid-Trimester Miscarriage |
| 10:00 |
Coffee Break & Poster Viewing |
| 10:30 |
Clinical Aspects of Ovarian Stimulation |
Industrial Session Sponsored by
WYETH |
Prenatal Screening & Diagnosis |
| 12:30 |
Luncheon Session Industrial Session
sponsored by Schering AG |
| 14:30 |
Minimal Workup Before Infertility Treatment |
Hysterectomy |
Thrombophilia In Obstetrics &Gynecology |
| 16:00 |
Coffee Break & Poster Viewing |
| 16:30 |
Male Infertility |
Breast Cancer |
Intrauterine Growth Restriction |
| SATURDAY,
APRIL 26, 2003 08:30–18:00 |
|
|
HALL A |
HALL B |
HALL C |
|
|
Infertility & ART |
Gynecology/ Menopause & Family Planning |
Perinatology & Prenatal Diagnosis |
| 08:30 |
Increasing Success Rate in IVF |
HRT Under Crossfire |
Coping with Infection in Obstetrics |
| 10:00 |
Coffee Break & Poster Viewing |
| 10:30 |
Demystifying Recombinant LH Sponsored by SERONO |
Treatment of Menopause - Risks Vs.Benefits Sponsored
by NOVO NORDISK |
Management of Pre-Term Labor Sponsored by FERRING
PHARMACEUTICALS |
| 13:00 |
Industrial Session sponsored by
Organon |
| 14:00red by IBSA |
Ovarian Stimulation for ART Sponso |
Ablation |
Prematurity |
| 16:00 |
Coffee Break & Poster Viewing |
| 16:30 |
Endometriosis |
Menopause |
Complications of Pregnancies |
| SUNDAY,
APRIL 27, 2003 08:30–15:30 |
|
|
HALL A |
HALL B |
HALL C |
|
|
Infertility & ART |
Gynecology/ Menopause & Family Planning |
Perinatology & Prenatal Diagnosis |
| 08:30 |
Antagonists for ART |
Aging Male |
Controversies in Neonatology I |
| 10:00 |
Coffee Break & Poster Viewing |
| 10:30 |
Pregnancy Loss |
Urogynecology |
The Breech Debate & Delivery Practice |
| 12:30 |
Lunch |
| 14:00 |
Embryo Transfer |
Myomectomy |
Controversies in Neonatology II |
